pfizer news - Search News

Pfizer names its head of oncology

Pfizer names oncology head Chris Boshoff as R&D chief

Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its R&D chief, WSJ reported on Wednesday.

The Wall Street Journal on MSN · 2d

Pfizer Names New R&D Chief

Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.

STAT · 2d

Doubling down on its strategy, Pfizer names its head of oncology as new research chief

Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.

Pfizer, BridgeBio and food and drug administration

BioPharma Dive · 8h

BridgeBio heart drug approved by FDA, setting up battle with Pfizer

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market that investors have been skeptical BridgeBio can win.

Bloomberg on MSN · 7h

BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer

BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way for the biotech company to go head-to-head with Pfizer Inc. in an increasingly competitive market.

Reuters on MSN · 7h

US FDA approves BridgeBio's drug for rare heart condition

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said on Friday, making it the first new treatment in a market dominated by Pfizer's blockbuster Vyndaqel.

17h

Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination

Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.

How Pfizer is trying to make U.S. healthcare easier to navigate

The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...

FierceBiotech20h

Chutes & Ladders—Pfizer replaces retiring CSO with cancer chief

Pfizer has found a successor for retiring Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the ...

FiercePharma19h

As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact

For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...

The Motley Fool on MSN2d

Is It Time to Sell Eli Lilly and Pfizer Stocks?

Lilly and Pfizer stocks have sold off sharply in recent weeks. Both drugmakers have had some bad news that caused their ...

FierceBiotech2d

Pfizer plucks internal candidate to replace R&D head Dolsten, triggering series of leadership shakeups

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own ...

BioWorld1d

Zai Lab, Pfizer team up to widen China access to antibacterial Xacduro

Zai Lab and Pfizer Inc. are teaming up in China to fight the deadly carbapenem-resistant Acinetobacter baumannii (CRAB) infection with novel antibacterial drug Xacduro (sulbactam-durlobactam).

Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules

A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Pfizer names its head of oncology

Pfizer, BridgeBio and food and drug administration

Related topics